Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag871 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Haley M Michel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Virginia Tech, Blacksburg, VA 24061, United States. Hauptthemen laut MEDLINE: RNA, DNA, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, Department of Agriculture National Institute of Food and Agriculture, NIGMS NIH HHS.
Abstract (Originalsprache)
The growing interest in nucleic acids as therapeutic targets has prompted the development of novel computational methods to facilitate drug discovery. In this study, we extend the Site Identification by Ligand Competitive Saturation (SILCS) methodology to characterize ligand–nucleic acid interactions using the Drude polarizable force field. We demonstrate the ability of the Drude force field to better model solute–nucleic acid interactions, resulting in improved identification of known binding sites and ligand binding favorability predictions across a diverse set of nucleic acid structures. This new workflow addresses limitations in previous SILCS studies by exploiting the enhanced sampling of solutes in the original SILCS-RNA workflow, accurately modeling the interactions of charged species, and improving solute sampling in minor groove binding sites. These results establish this Drude-based SILCS workflow as a valuable tool for structure-based drug design targeting nucleic acids and offer insights into solute preferences that can guide rational ligand design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Virginia Tech, Blacksburg, VA 24061, United States.
- University Libraries, Virginia Tech, Blacksburg, VA 24061, United States.
- Center for Drug Discovery, Virginia Tech, Blacksburg, VA 24061, United States.
- Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, United States.
ORCID-Profile: Justin A Lemkul
Förderung
- NIH HHS
- Department of Agriculture National Institute of Food and Agriculture
- NIGMS NIH HHS
- National Science Foundation
- Expanse Cluster at San Diego Supercomputer Center
- National Institutes of Health
Zitieren
APA
Michel, H. M., Brown, A. M., MacKerell, A. D., & Lemkul, J. A. (2026). Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag871
Vancouver
Michel HM, Brown AM, MacKerell AD, Lemkul JA. Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag871
BibTeX
@article{Michel2026,
author = {Michel, Haley M and Brown, Anne M and MacKerell, Alexander D and Lemkul, Justin A},
title = {Drude SILCS-Nucleic: harnessing explicit electronic polarization in targeting RNA and DNA for drug design},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag871}
}
EUVIMED